End of down trend?I see a hammer candle with it coming close to end of the trend line, which way will she go? I think to the upside since the candle! Let's go! Low float and lots of gap fills to upside still remain!
−3.87USD
−14.12 MUSD
7.30 MUSD
3.65 M
About Pulmatrix, Inc.
Sector
CEO
Teofilo Raad
Headquarters
Bedford
Website
Employees (FY)
22
Founded
2003
ISIN
US74584P3010
FIGI
BBG003TH2QL1
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Bedford, MA.
Bullish trend after a Bear attackMy partner and I predict this stock is going to spike exponentially by Friday next week.
$PULM Pattern moving #PULMVolume will continue to drive momentum or pullback to support before taking off!
PULM 1W Swing Editiontest
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based
PULM ASCENDING TRIANGLE?!An ascending triangle has a horizontal resistance line and usually occurs as a continuation of a bullish trend. Don't enter now. Overall trend is still downwards!
Chart structure on this looks fantastic. BIG OPP HERELooks to be close to bottom of descending and around the 2019 long term support. Clear skies above and this could realistically be a 10 bagger from here
Short Swing - 30min TFPrice finding solid support around 1.30. Traveling just below 50MA. Should make a move up towards 200MA and potential gap fill at 1.50+
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PULM is 2.09 USD — it has decreased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulmatrix, Inc. stocks are traded under the ticker PULM.
Pulmatrix, Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
PULM stock is 2.94% volatile and has beta coefficient of 0.36. Check out the list of the most volatile stocks — is Pulmatrix, Inc. there?
PULM earnings for the last quarter are −1.03 USD whereas the estimation was −1.05 USD which accounts for 1.90% surprise. Estimated earnings for the next quarter are −1.04 USD. See more details about Pulmatrix, Inc. earnings.
Pulmatrix, Inc. revenue for the last quarter amounts to 1.75 M USD despite the estimated figure of 1.86 M USD. In the next quarter revenue is expected to reach 1.80 M USD.
Yes, you can track Pulmatrix, Inc. financials in yearly and quarterly reports right on TradingView.
PULM stock has risen by 14.84% compared to the previous week, the month change is a 25.90% rise, over the last year Pulmatrix, Inc. has showed a 29.94% decrease.
PULM net income for the last quarter is −2.08 M USD, while the quarter before that showed −3.77 M USD of net income which accounts for 44.81% change. Track more Pulmatrix, Inc. financial stats to get the full picture.
Today Pulmatrix, Inc. has the market capitalization of 7.63 M, it has increased by 10.53% over the last week.
No, PULM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PULM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulmatrix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 22.00 employees. See our rating of the largest employees — is Pulmatrix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pulmatrix, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pulmatrix, Inc. stock shows the sell signal. See more of Pulmatrix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pulmatrix, Inc. EBITDA is −13.27 M USD, and current EBITDA margin is −181.76%. See more stats in Pulmatrix, Inc. financial statements.